Spectrum Brands (NYSE: SPB) CFO reports 4,971-share restricted stock grant

Rhea-AI Filing Summary

Spectrum Brands Holdings executive vice president and chief financial officer Faisal Qadir reported an acquisition of 4,971 shares of common stock on 12/12/2025. The shares reflect restricted stock units awarded at a price of $0 per share, and following this grant he beneficially owned 13,782 shares directly.

The restricted stock units are scheduled to vest on December 1, 2028, provided Qadir is an employee of Spectrum Brands on that date. This transaction represents routine equity compensation for a senior officer rather than an open-market purchase or sale.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Qadir Faisal

(Last) (First) (Middle)

C/O SPECTRUM BRANDS HOLDINGS, INC.

3001 DEMING WAY

(Street)

MIDDLETON WI 53562

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Spectrum Brands Holdings, Inc. [ SPB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & CFO

3. Date of Earliest Transaction (Month/Day/Year)
12/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/12/2025		A		4,971(1)	A	$0	13,782	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person was awarded restricted stock units which are settled in shares of common stock of the Issuer and which are scheduled to vest on December 1, 2028 if the Reporting Person is an employee of the Issuer on such date.

Remarks:

	/s/ Laurel McKellips, Attorney-in-fact for Faisal Qadir	12/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Spectrum Brands (SPB) report for Faisal Qadir?

The report shows that EVP & CFO Faisal Qadir was awarded restricted stock units covering 4,971 shares of Spectrum Brands common stock on 12/12/2025 at a price of $0 per share.

How many Spectrum Brands (SPB) shares does Faisal Qadir own after this transaction?

After the reported award, EVP & CFO Faisal Qadir beneficially owned 13,782 shares of Spectrum Brands common stock in direct ownership.

What are the vesting terms of the restricted stock units granted to Spectrum Brands (SPB) CFO?

The restricted stock units granted to Faisal Qadir are scheduled to vest on December 1, 2028, if he remains an employee of Spectrum Brands on that date.

Is the Spectrum Brands (SPB) CFO’s transaction a purchase on the open market?

No. The document describes an award of restricted stock units settled in shares of common stock, with $0 shown as the transaction price per share, indicating equity compensation rather than an open-market purchase.

What is Faisal Qadir’s role and relationship to Spectrum Brands (SPB)?

Faisal Qadir is reported as an officer of Spectrum Brands Holdings, Inc., serving as EVP & CFO. He is not identified as a director or a 10% owner in the report.

Does the Form 4 for Spectrum Brands (SPB) report any derivative securities for the CFO?

The report’s Table II for derivative securities shows no entries for acquisitions or dispositions, indicating no derivative security transactions were reported for this event.